This report presents the results of the zoonoses monitoring activities carried out in 2016 in 37 European countries (28 Member States (MS) and nine non-MS).
This guidance outlines the surveillance strategies and essential data requirements that Member States can use throughout the course of an influenza pandemic to ensure informed risk management decisions in pandemic response and fulfilment of IHR (2005) core capacity requirements.
This report covers six emerging issues: the environmental dimension of antimicrobial resistance; nanomaterials; Marine Protected Areas and sustainable development; sand and dust storms; off-grid solar solutions; and environmental displacement.
This guidance document provides healthcare epidemiologists working in acute-care hospitals with a high-level overview of incident management for infectious diseases outbreaks and to prepare them to work within an emergency response framework.
This report explores the fine line which exists between the successful eradication of polio and the risks that exists as the Global Polio Eradication Initiative (GPEI) winds down.
This strategy document discusses the World Organization for Animal Health's (OIE) five key areas for biothreat reduction.
This document seeks to provide a generic framework or template for implementing TB diagnostics; it encompasses the managerial, technical and operational processes required for developing and implementing a national strategy for TB laboratories.
This guidance reflects current understanding of MERS-CoV related to IPC and uses revised case definitions. The guidance is intended for health-care workers (HCWs), health-care managers, and IPC teams.
The intended audience for these recommendations are directors and managers of laboratories and TB programmes as well as the laboratory technicians who test for TB, especially in high-burden, low resource settings. In this document, the laboratory or section of the laboratory conducting TB testing is referred to as the TB laboratory.
This publication provides guidance on requirements under the Control of Substances Hazardous to Health Regulations 2002 (COSHH)1, 2 (as amended) as they relate to biological agents (micro-organisms/infection risks).